Newsmakers

Healthcare

CytoDyn (OTC: CYDY)Reports Significant Reduction in Breast Cancer Tumor Metastasis in Preclinical Study and Requests FDA Fast Track Designation for Leronlimab (PRO 140) in Metastatic-Triple Negative Breast Cancer (mTNBC)

March 12, 2019 admin Comments Off on CytoDyn (OTC: CYDY)Reports Significant Reduction in Breast Cancer Tumor Metastasis in Preclinical Study and Requests FDA Fast Track Designation for Leronlimab (PRO 140) in Metastatic-Triple Negative Breast Cancer (mTNBC)

VANCOUVER, Washington, March 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that leronlimab (PRO 140), […]

Consumer

Nightfood Ice Cream (OTC: NGTF) Expanding Distribution to Sixteen States; Second Production Run This Week, Initial Feedback is Strong

March 11, 2019 admin Comments Off on Nightfood Ice Cream (OTC: NGTF) Expanding Distribution to Sixteen States; Second Production Run This Week, Initial Feedback is Strong

Tarrytown, NY, March 11, 2019 — Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced that the second production run of Nightfood ice cream will begin this week, and […]

Healthcare

FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)

March 7, 2019 admin Comments Off on FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)

VANCOUVER, Washington, March 04, 2019 — CytoDyn Inc. (otc.qb:CYDY), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that the FDA has reviewed […]

Healthcare

CytoDyn (OTC: CYDY) to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019

February 28, 2019 admin Comments Off on CytoDyn (OTC: CYDY) to Present New Data from Study of Investigational HIV Therapy Leronlimab (PRO 140), a Long-Acting, Single-Agent Maintenance Therapy at CROI 2019

VANCOUVER, Washington, Feb. 27, 2019 — CytoDyn Inc. (OTC.QB: CYDY), a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that data from its study of leronlimab […]

Consumer

Nightfood (OTC: NGTF) Ice Cream Coupon Program Launches March 1st, Over 33,000 Consumer Sign-Ups to Date

February 28, 2019 admin Comments Off on Nightfood (OTC: NGTF) Ice Cream Coupon Program Launches March 1st, Over 33,000 Consumer Sign-Ups to Date

Tarrytown, NY, Feb 28, 2019 – Nightfood, Inc. (OTC QB: NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced that over 33,000 consumers across the country have already requested coupons for […]

Consumer

Nightfood (OTC: NGTF) Ice Cream Expands into California Through Distribution Partnership with Wonder Ice Cream of Santa Clara Adding 300 Independent Supermarkets; Highest Revenue Quarter in Company History

February 26, 2019 admin Comments Off on Nightfood (OTC: NGTF) Ice Cream Expands into California Through Distribution Partnership with Wonder Ice Cream of Santa Clara Adding 300 Independent Supermarkets; Highest Revenue Quarter in Company History

          TARRYTOWN, NY, Feb. 26, 2019  – Nightfood, Inc. (otcqb:NGTF), the innovative company solving America’s $50 billion-dollar nighttime snacking problem, has announced entry into the northern California market through a distribution […]

Healthcare

CytoDyn’s (OTC: CYDY) Leronlimab (PRO 140) reduces by more than 98% human breast cancer metastasis in mouse xenografts for over 6 weeks

February 20, 2019 admin Comments Off on CytoDyn’s (OTC: CYDY) Leronlimab (PRO 140) reduces by more than 98% human breast cancer metastasis in mouse xenografts for over 6 weeks

Based on strong results in its pre-clinical animal study, CytoDyn files for Orphan Drug Designation for Triple-Negative Breast Cancer VANCOUVER, Washington, Feb 20, 2019 – CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized […]

Healthcare

CytoDyn (OTC: CYDY) Announces Productive Conference Call with FDA Regarding First BLA Submission for Leronlimab (PRO 140) Combination Therapy at 700 mg Dose

February 7, 2019 admin Comments Off on CytoDyn (OTC: CYDY) Announces Productive Conference Call with FDA Regarding First BLA Submission for Leronlimab (PRO 140) Combination Therapy at 700 mg Dose

VANCOUVER, Washington, Feb 01, 2019 — Successful interim results in the 700 mg monotherapy arm prompted the FDA to allow CytoDyn to switch all remaining combination therapy patients from CD02-Extension study from 350 mg to […]

Newsmakers

FSD Pharma (OTC: FSDDF) Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

February 6, 2019 admin Comments Off on FSD Pharma (OTC: FSDDF) Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae

PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) FSD Pharma Inc. (“FSD Pharma”)(OTC: FSDDF)  and Solarvest BioEnergy Inc. (SVS) (“Solarvest”) ()Parties”), a technology company which has developed an algal-based flexible production platform […]

Mining & Metals

Cobalt 27 (OTC: CBLLF) Closes Royalties on Flemington Nickel-Cobalt Project and Nyngan Scandium Project in Australia

February 1, 2019 admin Comments Off on Cobalt 27 (OTC: CBLLF) Closes Royalties on Flemington Nickel-Cobalt Project and Nyngan Scandium Project in Australia

TORONTO, Jan. 18, 2019 – Cobalt 27 Capital Corp. (“Cobalt 27” or the “Company”) (TSXV: KBLT)(OTCQX: CBLLF)(FRA: 27O), a battery metals streaming and royalty company offering direct exposure to metals integral to electric vehicles and energy storage systems, today announced […]

Newsmakers

MedPharm Holdings Develops Innovative Cannabinoid Infused Dissolvable Oral Strip

January 31, 2019 admin Comments Off on MedPharm Holdings Develops Innovative Cannabinoid Infused Dissolvable Oral Strip

Today MedPharm Holdings announced the successful formulation and development of micro-emulsified, cannabis infused, dissolvable thin strips “Melts,” powered with their proprietary Lipophilic Enhanced Absorption Formulation (LEAF) technology. The oral strip is unique in that it […]

Newsmakers

Medicine Man Technologies, Inc. (OTC: MDCL) announces launch of direct operator division of licensed cannabis operations

January 18, 2019 admin Comments Off on Medicine Man Technologies, Inc. (OTC: MDCL) announces launch of direct operator division of licensed cannabis operations

DENVER – January 17, 2019 – Today Medicine Man Technologies (OTCQX: MDCL), a leading consulting, intellectual property licensing and products company in the cannabis industry, has announced a binding agreement that is expected to lead […]

Newsmakers

MEDICINE MAN TECHNOLOGIES (OTC: MDCL) Enters into Agreement to Acquire MedPharm Holdings, LLC

January 15, 2019 admin Comments Off on MEDICINE MAN TECHNOLOGIES (OTC: MDCL) Enters into Agreement to Acquire MedPharm Holdings, LLC

Medicine Man Technologies Adds Marijuana Research Company, Branded Product Lines and Intellectual Property Development Capabilities to Their International Base of Over 100 Clients DENVER, CO/ January 15, 2019 / Medicine Man Technologies (OTCQX: MDCL), a leading […]